PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse
Although the oncogenic role of PPFIA1 (liprin-α1) in breast cancer has been reported, whether its dysregulation is associated with metastasis risk or survival outcomes in breast cancer patients is not clear. Our primary data showed that PPFIA1 expression was significantly higher in liver metastatic...
Main Authors: | Jing Yang, Ning-Ni Wu, De-Jia Huang, Yao-Chang Luo, Jun-Zhen Huang, Hai-Yuan He, Hai-Lin Lu, Wen-Ling Song |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-07-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317713492 |
Similar Items
-
PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer
by: Lutfi H. Alfarsi, et al.
Published: (2020-05-01) -
PPFIA4 mutation: A second hit in POLG related disease?
by: Jo Sourbron, et al.
Published: (2021-01-01) -
PPFIA4 Promotes Colon Cancer Cell Proliferation and Migration by Enhancing Tumor Glycolysis
by: Jia Huang, et al.
Published: (2021-05-01) -
Detection of OSR2, VAV3, and PPFIA3 Methylation in the Serum of Patients with Gastric Cancer
by: Wen-han Li, et al.
Published: (2016-01-01) -
Prognostic Score for De Novo Metastatic Breast Cancer With Liver Metastasis and Its Predictive Value of Locoregional Treatment Benefit
by: Lei Ji, et al.
Published: (2021-08-01)